Skip to main content
News Mass 02.2020
Microscopic image of green stained macrophages after a stroke: The additional red stained cell (top right) originates from the bone marrow, the pure green cells are resident microglia.
© AG Stumm

Publication

Publication by Mass Group in Nature Neuroscience

Stroke: Macrophages migrate from the blood

Molecular switch in bone marrow stem cells helps research into inflammatory processes in the brain.

Macrophages are part of the innate immune system and essential for brain development and function. Using a novel method, scientists from Jena University Hospital, the Cluster of Excellence ImmunoSensation and the Memorial Sloan Kettering Cancer Center in New York (USA) succeeded in visualizing macrophages that were formed in the bone marrow. In studies on mice, this technology enabled the researchers to observe that shortly after a stroke, numerous macrophages that had migrated from the blood begin to attack dead and adjacent healthy brain tissue. The results have now been published in the journal "Nature Neuroscience". Prof. Elvira Mass - leading author of this publication - is a member of the Cluster of Excellence ImmunoSensation2.


Publication

Yves Werner, Elvira Mass, Praveen Ashok Kumar, Thomas Ulas, Kristian Händler, Arik Horne, Kathrin Klee, Amelie Lupp, Dagmar Schütz, Friederike Saaber, Christoph Redecker, Joachim L. Schultze, Frederic Geissmann & Ralf Stumm: Cxcr4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke, Nature Neuroscience, DOI: 10.1038/s41593-020-0585-y


Media contact

Prof. Dr. Elvira Mass

Life & Medical Sciences Institute (LIMES)

Universität Bonn

Tel. +49-(0)228-7362848

E-mail: elvira.mass@uni-bonn.de

Related news

The human P2X4 receptor

Publication

A starting point for the development of new pain and cancer drugs

—The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have now discovered a mechanism that can inhibit this receptor. The results were recently published in the scientific journal Nature Communications and open up a pathway for the development of new drugs. A study carried out by the University of Bonn and the University Hospital Bonn throws light on how P2X2 can be inhibited. The results have recently been published in Nature Communications.
View entry
Kato research group

Publication

Ominous false alarm in the kidney

—Bonn researchers have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering a chain reaction. In cooperation with Nanyang Technological University Singapore and the University Hospital Würzburg, among others, the study provides an explanation for how a point mutation in the immune receptor RIG-I transforms the body's defense system into a self-destructive force and causes severe organ-specific autoimmune diseases. The results have now been published in the journal Science Immunology.
View entry
News_Proebstel

Publication

Unique immune signatures to distinguish MOGAD from MS

—Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body’s immune system mistakenly attacks the protective myelin sheath of nerve fibers in the central nervous system. Although MOGAD induces symptoms similar to multiple sclerosis (MS), its underlying biology appears to be fundamentally different. Understanding these distinctions is crucial for developing effective, disease-specific treatments. A new international study now sheds light on these immune differences.
View entry

Back to the news overview